Inflammation-mediated Coronary Plaque Vulnerability, Myocardial Viability and Ventricular Remodeling

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2022

Conditions
Acute Myocardial InfarctionHeart Failure
Interventions
DIAGNOSTIC_TEST

Blood sampling

Assessment of complete blood count, biochemistry, inflammatory biomarkers, adhesion molecules

DIAGNOSTIC_TEST

transthoracic echocardiography

Assessment of the ventricular anatomy, size, function, speckle tracking, myocardial strain, valvular function.

DIAGNOSTIC_TEST

Late Gadolinium-Enhancement Cardiac Magnetic Resonance

Assessment of the ventricular anatomy, function, viability, degree of fibrosis, quantification of infarct size, mass.

DIAGNOSTIC_TEST

Coronary Angio Computed Tomography

Assessment of coronary plaque anatomy, morphology, vulnerability features, quantification of epicardial adipose tissue

Trial Locations (1)

540102

Cardio Med Medical Center, Târgu Mureş

Sponsors
All Listed Sponsors
collaborator

George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures

OTHER

collaborator

Tîrgu Mureș Emergency Clinical County Hospital, Romania

OTHER

lead

Cardio Med Medical Center

INDUSTRY